Omeprazole Capsule, Delayed Release
Product Images NDC 55154-2332

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Omeprazole (NDC 55154-2332). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5bab7d0b 05d8 4781 Afd9 8df55c925c9c 01

FDA Label Image

Image 01

Image 01
OMEPRAZOLE is a medication available in delayed-release capsules, with 20 mg each for adults to treat certain stomach and esophagus problems. Complete prescribing information, precautions, and warnings are included in the package insert or the medguide found at majorpharmaceuticals.com. The medication should be stored in a container that is securely sealed, resistant to light, and moisture at controlled room temperature. This unit dose packaging is not child-resistant, thus intended for institutional use only. Cadia Healthcare Ltd in Ahmedabad, India, manufactured the product, with 2Zydus Pharmaceuticals USA Inc, distributing it in Pennington, NJ, and Cardinal Health in Dublin, Ohio.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.